Class Actions · Mass Torts · Securities FraudCall (918) 238-6445

Attorney advertisingBriefCorporate & Governance

Delaware Chancery awards Nephrosant $8 million against ousted co-founder

Responsible attorney: Lou Schwartz, Schwartz & Associates, PC, Atlanta, Georgia. intake@snalawyers.com

A Delaware Court of Chancery vice chancellor issued a post-trial memorandum opinion finding that Nephrosant co-founder Minnie Sarwal concealed changes to the company's flagship kidney-transplant rejection test, destroyed company files, and courted investors for a competing venture. The court awarded Nephrosant nearly $8 million in damages on its counterclaims against Sarwal. The ruling resolves litigation that began when Sarwal sued seeking advancement and indemnification after the company's board ousted her following an internal investigation.

Why it matters. The decision illustrates Delaware courts' willingness to impose substantial personal monetary liability on a founder found to have concealed information and misappropriated company assets, a precedent relevant to other founder-ouster and corporate-opportunity disputes.

Sources

  1. Chancery Hits Kidney Test Founder With $8M Judgment (law360.com) secondary
  2. Delaware Courts Opinions and Orders list (courts.delaware.gov)

Briefs summarize public developments. Unless stated otherwise, the firm is not counsel in the matters described, and allegations are not findings.

General information, not legal advice. Reading this article or using the intake assistant does not create an attorney-client relationship.

If something happened to more people than you, tell us.

Many class actions begin with one person who noticed a pattern. Reviewing your information costs nothing and creates no obligation.